123 related articles for article (PubMed ID: 12175745)
1. Effect of supersaturation and crystallization phenomena on the release properties of a controlled release device based on EVA copolymer.
van Laarhoven JA; Kruft MA; Vromans H
J Control Release; 2002 Aug; 82(2-3):309-17. PubMed ID: 12175745
[TBL] [Abstract][Full Text] [Related]
2. In vitro release properties of etonogestrel and ethinyl estradiol from a contraceptive vaginal ring.
van Laarhoven JA; Kruft MA; Vromans H
Int J Pharm; 2002 Jan; 232(1-2):163-73. PubMed ID: 11790500
[TBL] [Abstract][Full Text] [Related]
3. Influence of spinline stress on release properties of a coaxial controlled release device based on EVA polymers.
van Laarhoven H; Veurink J; Kruft MA; Vromans H
Pharm Res; 2004 Oct; 21(10):1811-7. PubMed ID: 15553227
[TBL] [Abstract][Full Text] [Related]
4. Sustained release from hot-melt extruded matrices based on ethylene vinyl acetate and polyethylene oxide.
Almeida A; Brabant L; Siepmann F; De Beer T; Bouquet W; Van Hoorebeke L; Siepmann J; Remon JP; Vervaet C
Eur J Pharm Biopharm; 2012 Nov; 82(3):526-33. PubMed ID: 22986082
[TBL] [Abstract][Full Text] [Related]
5. Application of mixtures of polymeric carriers for dissolution enhancement of fenofibrate using hot-melt extrusion.
Kalivoda A; Fischbach M; Kleinebudde P
Int J Pharm; 2012 Jun; 429(1-2):58-68. PubMed ID: 22440149
[TBL] [Abstract][Full Text] [Related]
6. A comparative study between hot-melt extrusion and spray-drying for the manufacture of anti-hypertension compatible monolithic fixed-dose combination products.
Kelleher JF; Gilvary GC; Madi AM; Jones DS; Li S; Tian Y; Almajaan A; Senta-Loys Z; Andrews GP; Healy AM
Int J Pharm; 2018 Jul; 545(1-2):183-196. PubMed ID: 29730176
[TBL] [Abstract][Full Text] [Related]
7. The Development of Quasi-isothermal Calorimetry for the Measurement of Drug-Polymer Miscibility and Crystallization Kinetics: Olanzapine-Loaded PLGA Microparticles.
Askin S; Zhao M; Gonçalves AD; Gaisford S; Craig DQM
Mol Pharm; 2018 Aug; 15(8):3332-3342. PubMed ID: 29933697
[TBL] [Abstract][Full Text] [Related]
8. Ethylene vinyl acetate as matrix for oral sustained release dosage forms produced via hot-melt extrusion.
Almeida A; Possemiers S; Boone MN; De Beer T; Quinten T; Van Hoorebeke L; Remon JP; Vervaet C
Eur J Pharm Biopharm; 2011 Feb; 77(2):297-305. PubMed ID: 21168487
[TBL] [Abstract][Full Text] [Related]
9. Investigating the feasibility of temperature-controlled accelerated drug release testing for an intravaginal ring.
Externbrink A; Clark MR; Friend DR; Klein S
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):966-73. PubMed ID: 23791685
[TBL] [Abstract][Full Text] [Related]
10. Controlled release of atenolol from the ethylene-vinyl acetate matrix.
Kim J; Shin SC
Int J Pharm; 2004 Apr; 273(1-2):23-7. PubMed ID: 15010126
[TBL] [Abstract][Full Text] [Related]
11. Application of mixtures of polymeric carriers for dissolution enhancement of oxeglitazar using hot-melt extrusion.
Kalivoda A; Fischbach M; Kleinebudde P
Int J Pharm; 2012 Dec; 439(1-2):145-56. PubMed ID: 23073606
[TBL] [Abstract][Full Text] [Related]
12. Ethylene vinyl acetate (EVA) as a new drug carrier for 3D printed medical drug delivery devices.
Genina N; Holländer J; Jukarainen H; Mäkilä E; Salonen J; Sandler N
Eur J Pharm Sci; 2016 Jul; 90():53-63. PubMed ID: 26545484
[TBL] [Abstract][Full Text] [Related]
13. Properties of melt extruded enteric matrix pellets.
Schilling SU; Shah NH; Waseem Malick A; McGinity JW
Eur J Pharm Biopharm; 2010 Feb; 74(2):352-61. PubMed ID: 19782133
[TBL] [Abstract][Full Text] [Related]
14. Insights into Factors Affecting Ethylene-Vinyl Acetate Copolymer Crystallinity in Islatravir Implant.
Zhu X; Punia A; Skomski D; Su Y; Shultz CS; Giles MB; Rudd ND; Raman N; Koynov A; Lamm MS
Mol Pharm; 2024 Apr; 21(4):1933-1941. PubMed ID: 38502549
[TBL] [Abstract][Full Text] [Related]
15. Enhanced controlled release of loratadine from the ethylene-vinyl acetate matrix containing plasticizer.
Cho CW; Kim SJ; Yang KH; Song JH; Jeong HJ; Shin SC
Drug Deliv; 2008 Sep; 15(7):423-8. PubMed ID: 18712619
[TBL] [Abstract][Full Text] [Related]
16. Controlled release of triprolidine using ethylene-vinyl acetate membrane and matrix systems.
Shin SC; Lee HJ
Eur J Pharm Biopharm; 2002 Sep; 54(2):201-6. PubMed ID: 12191692
[TBL] [Abstract][Full Text] [Related]
17. Preparation, characterization and properties of partially hydrolyzed ethylene vinyl acetate copolymer films for controlled drug release.
Tang M; Hou J; Lei L; Liu X; Guo S; Wang Z; Chen K
Int J Pharm; 2010 Nov; 400(1-2):66-73. PubMed ID: 20804834
[TBL] [Abstract][Full Text] [Related]
18. [Study on the properties of felodipine solid dispersions prepared by different technologies].
Shi NQ; Zhang H; Zhang Y; Feng B; Li ZQ; Qi XR
Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Dec; 48(6):1067-1073. PubMed ID: 27987515
[TBL] [Abstract][Full Text] [Related]
19. Upscaling and in-line process monitoring via spectroscopic techniques of ethylene vinyl acetate hot-melt extruded formulations.
Almeida A; Saerens L; De Beer T; Remon JP; Vervaet C
Int J Pharm; 2012 Dec; 439(1-2):223-9. PubMed ID: 23018111
[TBL] [Abstract][Full Text] [Related]
20. Crystal growth formation in melt extrudates.
Bruce C; Fegely KA; Rajabi-Siahboomi AR; McGinity JW
Int J Pharm; 2007 Aug; 341(1-2):162-72. PubMed ID: 17524578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
